USANA Health Sciences, Inc. (USNA): Price and Financial Metrics

USANA Health Sciences, Inc. (USNA): $103.22

0.53 (+0.52%)

POWR Rating

Component Grades














  • Quality is the dimension where USNA ranks best; there it ranks ahead of 99.93% of US stocks.
  • USNA's strongest trending metric is Value; it's been moving down over the last 31 weeks.
  • USNA ranks lowest in Momentum; there it ranks in the 34th percentile.

USNA Stock Summary

  • Usana Health Sciences Inc's capital turnover -- a measure of revenue relative to shareholder's equity -- is better than 83.69% of US listed stocks.
  • Of note is the ratio of Usana Health Sciences Inc's sales and general administrative expense to its total operating expenses; only 17.98% of US stocks have a lower such ratio.
  • For USNA, its debt to operating expenses ratio is greater than that reported by only 0.51% of US equities we're observing.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Usana Health Sciences Inc are WIRE, LZB, JOUT, MNDO, and WERN.
  • Visit USNA's SEC page to see the company's official filings. To visit the company's web site, go to

USNA Valuation Summary

  • In comparison to the median Consumer Defensive stock, USNA's price/sales ratio is 37.93% lower, now standing at 1.8.
  • USNA's price/sales ratio has moved up $1.6 over the prior 243 months.

Below are key valuation metrics over time for USNA.

Stock Date P/S P/B P/E EV/EBIT
USNA 2016-11-14 1.6 5.0 15.0 9.8
USNA 2016-03-14 1.6 5.1 15.1 9.0
USNA 2012-11-26 1.0 3.2 10.3 6.1
USNA 2012-09-26 1.1 3.5 11.6 6.9
USNA 2011-04-11 1.0 3.7 11.9 7.5
USNA 2008-06-27 1.0 8.6 10.4 6.7

USNA Stock Price Chart Interactive Chart >

Price chart for USNA

USNA Price/Volume Stats

Current price $103.22 52-week high $107.85
Prev. close $102.69 52-week low $68.30
Day low $101.79 Volume 34,088
Day high $103.51 Avg. volume 107,103
50-day MA $100.19 Dividend yield N/A
200-day MA $87.37 Market Cap 2.13B

USANA Health Sciences, Inc. (USNA) Company Bio

USANA Health Sciences develops and manufactures nutritional supplements, healthy foods and personal care products. The company was founded in 1992 and is based in Salt Lake City, Utah.

USNA Price Forecast Based on DCF Valuation

Current PriceDCF Fair Value Target: Forecasted Gain:
$103.22$55.33 -46%

We started the process of determining a valid price forecast for Usana Health Sciences Inc with a discounted cash flow analysis -- the results of which can be found in the table below. To summarize, we found that Usana Health Sciences Inc ranked in the 38th percentile in terms of potential gain offered. We should note, though, that the most conservative analysis suggests this stock will yield negative results -- and thus may be a potential short opportunity. In terms of the factors that were most noteworthy in this DCF analysis for USNA, they are:

  • The stock's equity weight, or the proportion of capital from equity relative to debt, is 100. Its equity weight surpasses that of 98.67% of free cash flow generating stocks in the Consumer Defensive sector.
  • The business' balance sheet reveals debt to be 0% of the company's capital (with equity being the remaining amount). Approximately just 0% of US stocks with free cash flow have a lower reliance on debt in their capital structure.
  • USNA's estimated cost of debt, based largely on its market capitalization and its interest coverage ratio, is 3%; for context, that number is higher than 63.85% of tickers in our DCF set.

Terminal Growth Rate in Free Cash FlowReturn Relative to Current Share Price

For other companies in the Consumer Defensive that have a similar discounted cashflow valuation profile (and ensuing price forecasts) as USNA, try CCEP, DAR, FLO, CHGG, and COST.

USNA Latest News Stream

Event/Time News Detail
Loading, please wait...

USNA Latest Social Stream

Loading social stream, please wait...

View Full USNA Social Stream

Latest USNA News From Around the Web

Below are the latest news stories about Usana Health Sciences Inc that investors may wish to consider to help them evaluate USNA as an investment opportunity.

Love Your Body. Change Your World. USANA Proudly Launches New Product Line

USANA Health Sciences, a global leader in nutrition, is proud to announce its brand-new USANA Active Nutrition product line. Launched to the public on June 15, 2021 in the United States, Canada, and Mexico, Active Nutrition features seven new products formulated to give customers the most positive and fulfilling health journey possible. From weight management to digestive health to energy and hydration, Active Nutrition has your body covered.*

Yahoo | June 15, 2021

Introducing USANA Health Sciences (NYSE:USNA), A Stock That Climbed 85% In The Last Five Years

When you buy and hold a stock for the long term, you definitely want it to provide a positive return. Better yet, you'd...

Yahoo | June 11, 2021

USANA director of human resources awarded for outstanding achievement her in field

USANA extends a huge congratulations to its Director of Human Resources Sheena Blauvelt for being honored by Utah Business Magazine with their HR Achievement Award. Sheena was awarded for her outstanding human resources work with USANA and its employees.

Yahoo | June 7, 2021

Heart Health Supplements Market Is Booming Across the Globe Explored in Latest Report 2021-2026| Bayer AG, USANA Health Sciences, Inc., Sanofi , Koninklijke DSM N.V., Pfizer Inc

Heart Health Supplements Global Market 2021 research report presents analysis of market size, share, and growth, trends, cost structure, statistical and comprehensive data of the global market. The Market report offers noteworthy data regarding industrys growth parameters, the current state

OpenPR | May 23, 2021

USANA and Beijing University of Chinese Medicine ink research collaboration agreement

USANA Health Sciences ([[USNA]] +0.9%) and Beijing University of Chinese Medicine sign research collaboration agreement.The objective of the collaboration is to bring together modern nutritional science and traditional Chinese medicine ((TCM)).Under the agreement, USANA has the right to commercialize any nutritional/TCM products resulting from the collaboration....

Seeking Alpha | May 21, 2021

Read More 'USNA' Stories Here

USNA Price Returns

1-mo 3.31%
3-mo 4.81%
6-mo 30.87%
1-year 26.32%
3-year -12.78%
5-year 83.62%
YTD 33.88%
2020 -1.85%
2019 -33.28%
2018 58.99%
2017 21.00%
2016 -4.19%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.9357 seconds.